Brexit – Effect On UK Healthcare Policy “Hard To Say”
This article was originally published in Clinica
Stick to the evidence. Scientists tend to. It is claimed that this principle runs like a seam through the UK’s EU dealings on health issues, healthcare delivery and the healthcare products industry. Doubtless as it may in other EU nations, but none of the EU27 is at present faced with having to give the EU a vote of confidence
You may also be interested in...
If the tools are not in place by the end of 2020 to allow diagnostics companies to comply with the EU IVDR, the 2022 compliance deadline should be delayed, say EU notified bodies.
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.